Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Reviewing BrainsWay (NASDAQ:BWAY) and Paradigm Medical Industries (OTCMKTS:PDMI)
BrainsWay (NASDAQ:BWAY – Get Free Report) and Paradigm Medical Industries (OTCMKTS:PDMI – Get Free Report) are both medical companies, but...
Reviewing Heartland Financial USA (NASDAQ:HTLF) & Orrstown Financial Services (NASDAQ:ORRF)
Orrstown Financial Services (NASDAQ:ORRF – Get Free Report) and Heartland Financial USA (NASDAQ:HTLF – Get Free Report) are both finance...
Contrasting Stein Mart (OTCMKTS:SMRTQ) & GAP (NYSE:GAP)
GAP (NYSE:GAP – Get Free Report) and Stein Mart (OTCMKTS:SMRTQ – Get Free Report) are both retail/wholesale companies, but which...
Brokerages Set Constellium SE (NYSE:CSTM) PT at $21.00
Shares of Constellium SE (NYSE:CSTM – Get Free Report) have been given an average rating of “Moderate Buy” by the...
Reviewing Pharma-Bio Serv (OTCMKTS:PBSV) & 1847 (OTCMKTS:EFSH)
Institutional & Insider Ownership 6.3% of 1847 shares are owned by institutional investors. 4.0% of 1847 shares are owned by...
Contrasting Bancorp (NASDAQ:TBBK) & Solera National Bancorp (OTCMKTS:SLRK)
Solera National Bancorp (OTCMKTS:SLRK – Get Free Report) and Bancorp (NASDAQ:TBBK – Get Free Report) are both finance companies, but...